secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2022-03-14T23:59:59+00:00
Accession:  0001558370-22-003560
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Olema CSO Peter Kushner transitions to non-executive Senior Research Fellow role
--------------------------------------------------------------------------------

- Peter Kushner, Ph.D., steps down as Chief Scientific Officer effective April 1, 2022.
- Kushner will remain with company as Senior Research Fellow and Co-Founder.
- No replacement for CSO role announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000155837022003560/0001558370-22-003560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000155837022003560/olma-20220310x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-003560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer